Revelation Biosciences, Inc. - stock earnings
REVB Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -2.6 million USD | ? USD |
| 2023Q2 | -1.4 million USD | ? USD |
| 2023Q1 | 13.9 million USD | ? USD |
| 2022Q4 | -1.2 million USD | ? USD |
| 2022Q3 | -1.1 million USD | ? USD |
| 2022Q2 | -1.8 million USD | ? USD |
| 2022Q1 | -3.9 million USD | ? USD |
| 2021Q4 | -3.9 million USD | ? USD |
| 2021Q3 | -3.0 million USD | ? USD |
| 2021Q2 | -2.5 million USD | ? USD |
| 2021Q1 | -2.6 million USD | ? USD |
| 2020Q3 | -868 USD | ? USD |
| 2019Q4 | 8.0 million USD | 25.1 million USD |
| 2019Q3 | 8.2 million USD | 24.8 million USD |
| 2019Q2 | 7.9 million USD | 23.7 million USD |
| 2019Q1 | 7.5 million USD | 22.2 million USD |
| 2018Q4 | 7.2 million USD | 21.5 million USD |
| 2018Q3 | 7.0 million USD | 20.6 million USD |
| 2018Q2 | 6.9 million USD | 19.9 million USD |
| 2018Q1 | 6.6 million USD | 19.1 million USD |
| 2017Q4 | 2.8 million USD | 18.8 million USD |
| 2017Q3 | 5.1 million USD | 18.3 million USD |
| 2017Q2 | 4.9 million USD | 17.3 million USD |
| 2017Q1 | 3.5 million USD | 16.4 million USD |
REVB Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 875063 USD | ? USD |
| 2022 | -10.8 million USD | ? USD |
| 2021 | -12.0 million USD | ? USD |
| 2020 | -136408 USD | ? USD |
| 2019 | -3638 USD | 95.8 million USD |
| 2018 | 27.6 million USD | 85.1 million USD |
| 2017 | 16.3 million USD | 74.0 million USD |
| 2016 | 8.8 million USD | 48.8 million USD |
| 2015 | 6.2 million USD | 27.7 million USD |
| 2014 | 4.5 million USD | 21.1 million USD |
REVB
Price: $2.37
52 week price:
Earnings Per Share: -0.53 USD
P/E Ratio: -1.19
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 562000
Market Capitalization: 3.4 million